قالب وردپرس درنا توس
Home / Health / help Wanted! Conduct clinical trials to test the COVID-19 vaccine

help Wanted! Conduct clinical trials to test the COVID-19 vaccine



The National Institutes of Health is seeking the help of thousands of Americans to participate in a new clinical trial to test various vaccines and antibodies designed to protect people from COVID-19. Since the emergence of the coronavirus pandemic, most hope for normalization has relied on the development of vaccines that can greatly reduce the risk of infection and thus help prevent the spread of the virus. Federal officials have established an online registration form to recruit people from different ages, races and health backgrounds to test potential vaccines. Dr. Todd Ellerin of South Shore Health said: “In the Phase 3 trial, you can determine whether the vaccine is effective and can be used safely in large quantities.”

; Dr. Anthony Fauci said: “Having a preventive COVID The safe and effective medical countermeasures of -19 not only enable us to save lives, but also help to end the global pandemic.” “Concentrating our clinical research work into a single trial network will expand effective identification against COVID- 19 resources and expertise required for safe and effective vaccines and other prevention strategies.” More than 100 clinical trial sites will be established in the United States and internationally. The network has established an extensive community participation framework to reach potential research volunteers and explain the specific details of participating in clinical studies of vaccines or monoclonal antibodies. People can also visit the COVPN website to learn more about the different stages of vaccine research and the new network of COVID-19 vaccine and monoclonal antibody research. The COVPN website has a customized data collection platform that can safely identify potential trial participants. Individuals who are interested can register on the website for the rolling clinical trial participant registry, which has enhanced security protection. Clinical researchers will use the registration form to contact and screen potential research volunteers. A new survey designed by a team at Tufts University found that only 57% of Americans said they would get COVID-Tufts University Health, Wealth, and Citizen Participation Fairness Research Group designed and analyzed this In a national survey, about 42% of the respondents indicated that they would not be vaccinated (18%) or uncertain whether they would be vaccinated (24%). “What’s really worrying is that only 57% of the respondents said they would be vaccinated. Obviously, we now need to start developing a national vaccine strategy and conduct an education campaign-even before the vaccine is available,” Jennifer Allen (Jennifer Allen) said a professor at Tufts University and the co-lead of the study. Tufts University’s research results show that different populations have different degrees of acceptance of vaccination.

The National Institutes of Health is seeking the help of thousands of Americans to participate in a new clinical trial to test various vaccines and antibodies designed to protect people from COVID-19.

Since the emergence of the coronavirus pandemic, most hope for normalization has relied on the development of vaccines that can greatly reduce the risk of infection and thus help prevent the spread of the virus.

Federal officials have established an online registration form to recruit people from different ages, races and health backgrounds to test potential vaccines.

Dr. Todd Ellerin of South Shore Health said: “In the Phase 3 trial, you can determine whether the vaccine is effective and can be safely used in large quantities.”

Dr. Anthony Fauci said: “Having a safe and effective medical strategy to prevent COVID-19 not only enables us to save lives, but also helps to end the global pandemic.” “Concentrating our clinical research work into a single The trial network will expand the resources and expertise required to effectively identify safe and effective vaccines and other prevention strategies for COVID-19.”

More than 100 clinical trial sites will be launched in the United States and worldwide.

The network has established an extensive community participation framework to reach potential research volunteers and explain the specific details of participating in clinical studies of vaccines or monoclonal antibodies.

People can also visit the COVPN website to learn more about the different stages of vaccine research and the new network of COVID-19 vaccine and monoclonal antibody research.

The COVPN website has a customized data collection platform that can safely identify potential trial participants. Individuals who are interested can register on the website for the rolling clinical trial participant registry, which has enhanced security protection.

Clinical researchers will use the registration form to contact and screen potential research volunteers.

A new survey designed by a team at Tufts University shows that the requirement for Americans to help find vaccines is that only 57% of Americans say they will get the COVID-19 vaccine if they can buy it today.

A national survey designed and analyzed by the Tufts University Health, Wealth, and Citizen Participation Equity Research Group showed that about 42% of respondents said they would not be vaccinated (18%) or were unsure whether they would be vaccinated (24%) .

“What’s really worrying is that only 57% of the respondents said they would be vaccinated. Obviously, we now need to start developing a national vaccine strategy and conduct an education campaign-even before the vaccine is available,” Jennifer Allen (Jennifer Allen) said a professor at Tufts University and the co-lead of the study.

Tufts said the results revealed different levels of acceptance of vaccination among different groups.


Source link